Skip to Main Content


A Discussion of Global Health and PEPFAR from 2008

By | Leave a Comment

 PEPFARDuring the O’Neill Institute Colloquium in 2008, Ambassador Mark R. Dybul, U.S. Global AIDS Coordinator at the time, addressed current and emerging issues related to President Bush’s Emergency Plan for AIDS Relief (PEPFAR).  In this video, Amb. Dybul presents a historical framework for PEPFAR and discusses the implications of its recent (2008) re-authorization.

Ambassador Mark R. Dybul is currently the Executive Director of the Global Fund for AIDS, Tuberculosis and Malaria. At the O’Neill Institute, he was co-director of the Global Health Law Program, where he was also a Distinguished  Scholar.  He was also the Global Health Fellow at the George W. Bush Institute.  In addition, he was Senior Counselor for the Global Business Coalition on HIV, Tuberculosis and Malaria.

Ambassador Dybul served as the United States Global AIDS Coordinator from 2006 to the end of the Bush Administration. In that role, he led the implementation of the President’s Emergency Plan for AIDS Relief (PEPFAR), the largest international health initiative in history for a single disease.  He oversaw U.S. government engagement in the Global Fund to Fight AIDS, Tuberculosis and Malaria and was Chair of the Finance and Audit Committee. He also served as chair of the Joint United Nations Programme on AIDS’ coordinating board and as a member of the board of trustees of the Woodrow Wilson International Center for Scholars.

Prior to assuming the post of Ambassador, Dr. Dybul was Acting, Deputy and Assistant Coordinator, and was a member of the Planning Task Force that created PEPFAR.  In the various roles, he was the principal architect of the initial plan and implementation of PEPFAR.  He also led President Bush’s International Prevention of Mother and Child HIV initiative at the Department of Health and Human Services (HHS), was the Executive Secretary for HHS guideline for adult and adolescent HIV therapy and was a member of the writing committee for the World Health Organization’s guidelines on the use of antiretroviral therapy. At HHS, Dr. Dybul served as the assistant director for medical affairs at the National Institute of Allergy and Infectious Diseases and the National Institutes of Health and was the principal investigator of basic and clinical research with as particular emphasis on HIV treatment in Africa.

Ambassador Dybul is well published in scientific and policy literature.  He has received several Honorary Degrees and significant awards.  He currently serves on numerous national and international Boards.

Dr. Dybul received his A.B. in philosophy and M.D. from Georgetown University before completing a residency in Internal Medicine at the University of Chicago Hospitals in 1992 and a fellowship in Infectious Diseases from the National Institute of Allergy and Infectious Diseases in 1995.

The O’Neill Institute Colloquium, offered annually, is an interdisciplinary course that draws from the work of scholars, policymakers, and the general health community. The course is taught and moderated by Institute-affiliated faculty, and the goal of the Colloquium is to engage leading thinkers and students in an enriching dialogue regarding critical health law issues. National and international scholars, practitioners and policymakers explore contemporary health issues with top students interested in health law and related issues from schools throughout the University. The Colloquium sessions are open to University faculty members and interested members of the public.


Thematic Areas:

Comments are closed.

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.